Management of acute ischaemic stroke

Acta Clinica Belgica

Volumn 54, Issue 5, 1999, Pages 302-305

  De Keyser, J ^a   Sulter, G ^b   Langedijk, M ^b   Elting, J W ^b   Van Der Naalt, J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Focal brain ischaemia; Ischaemic stroke; Stroke treatment; Stroke units; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; NEUROPROTECTIVE AGENT;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HUMAN; MORBIDITY; MORTALITY; NEUROPROTECTION; SECONDARY PREVENTION;

EID: 0032722699     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1999.11754250     Document Type: Conference Paper

References (25)

1. Pulsinelli W. Pathopysiology of acute ischaemic stroke. Lancet 1992; 339: 533-36.
2. De Keyser J, Sulter G, Luiten PAG. Clinical trials with neuro-protective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 1999 (in press).
3. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346: 1509-14.
4. Donnan GA, Davis SM, Chambers BR; for the Australian Streptokinase (ASK) Trial Study Group. Streptokinase for acute ischaemic stroke with relationship to time of administration. JAMA. 1996; 276: 961-6.
5. Hommel M, Cornu C, Boutitie F, Boissel JP. Multicentre Acute Stroke Trial Europe: thrombolytic therapy with streptokinase in acute ischaemic stroke. N Engl J Med 1996; 335: 145-50.
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995; 333: 1581-87.
7. Hacke W, Kaste M, Fieschi C, et al. Intravenous Thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
8. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-51.
9. Albers GW, Clark WM, for the ATLANTIS Study Investigators. The ATLANTIS rt-PA (Alteplase) acute stroke trial: final results. Cerebrovasc Dis 1999; 9 (Suppl 1): 126 (abstr).
10. Ford G, Freemantle N. ECASS-II: intravenous alteplase in acute ischaemic stroke. Lancet 1999; 353: 65.
11. Lees K. ECASS-II: intravenous alteplase in acute ischaemic stroke. Lancet 1999; 353: 65-66.
12. Grond M, Stenzel C, Schmülling S, et al. Early intravenous thrombolysis for acute ischaemic stroke in a community-based approach. Stroke 1998; 29: 1544-49.
13. Practice advisory: Thrombolytic therapy for acute ischaemic stroke - Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996; 47: 835-9.
14. Powers WJ. Acute hypertension after stroke: the scientific basis for treatment desicions. Neurology. 1993; 43: 461-467.
15. Sulter G, De Keyser J. From stroke unit care to stroke care unit. J Neurol Sci 1999; 162: 1-5.
16. Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke. 1997; 28: 2133-38.
17. Back T, Kohno K, Hossman KA. Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram. J Cereb Blood Flow Metab. 1994; 14: 12-19.
18. Mikel HS, Yashes NV, Kempinski O, von Lubitz D, Weiss JF, Feuerstein G. Breathing 100% oxygen after global brain ischaemia in Monogolian gerbils results in increased lipid peroxidation and increased mortality. Stroke. 1987; 18: 426-30.
19. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. Brit Med J. 1997; 314: 1303-06.
20. Wass CT, Lanier WL. Glucose modulation of ischaemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996; 71: 801-12.
21. Bogousslavsky J, De Keyser J, Diener HC, et al. Neuroprotection as initial therapy in acute stroke. Cerebrovascular Dis 1998, 8: 59-72
22. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke. A significant clinical concern. Stroke. 1998;29:529-534.
23. De Keyser J. Antipyretics in acute ischaemic stroke. Lancet 1998; 352: 6-7.
24. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Brit Med J. 1997; 314: 1151-1159.
25. Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin. 1992; 10: 167-176.